Stereotaxis, Inc. (STXS)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. | CEO & Chairman | 62.2k | -- | 1987 |
Ms. Kimberly R. Peery | CFO & Secretary | 251.76k | -- | 1969 |
Mr. Keith Galloway | Vice President of Operations | -- | -- | -- |
Ms. Laura Spencer Garth | General Counsel & Secretary | -- | -- | -- |
Mr. Guy Judkowski | Equity Portfolio Manager | -- | -- | -- |
Stereotaxis, Inc.
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees:
- 122
Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Corporate Governance
Recent Events
- Apr 08, 2024DEFA14A: Proxy StatementsSee Full Filing
- Apr 04, 2024DEFA14A: Proxy StatementsSee Full Filing
- Mar 08, 202410-K: Periodic Financial ReportsSee Full Filing
- Mar 04, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Nov 13, 202310-Q: Periodic Financial ReportsSee Full Filing